Istanbul Medipol University Genetic Diseases Assessment Center has been accredited by TÜRKAK in accordance with the TS EN ISO 15189:2014 standard, effective as of April 5, 2022. We congratulate our esteemed managers and team for their successful work.
Let’s get to know our unit better thanks to our interview with MEDIGEN director Prof. Dr. Turkan Yigitbasi.
Who is Prof. Dr. Türkan Yiğitbaşı? Can you tell us a little about yourself?
I graduated from Ege University Faculty of Medicine in 1988. In 1994, I completed my Biochemistry and Clinical Biochemistry specialization training in the Department of Biochemistry at Erciyes University. I worked as a clinical laboratory director and lecturer at Kayseri State Hospital, Private Diagnostic Center, Baylor College of Medicine in the USA, and Regional Hygiene Institute in Izmir and Katip Çelebi University Atatürk Training and Research Hospital. I have been working as a faculty member at Istanbul Medipol University Faculty of Medicine, Department of Medical Biochemistry since 2012 and as the director of Medipol University Genetic Evaluation Center since 2016.
It was some time after Genetic Diseases Assessment Center was licensed. The task was entrusted by Founding Rector Prof. Dr. Sabahattin Aydın and our Rector Prof. Dr. Ömer Ceran. I continue to work with the effort to do my best.
Our Genetic Diseases Assessment Center started its activities in 2016 within our university. Since 2016, it has increased its test diversity from 3 to 590, and the number of domestic and international laboratories it serves to 87. Today, it continues its services as an accredited laboratory with its 36 experienced and professionally qualified personnel.
Our center provides services in the fields of molecular genetics, molecular karyotyping, molecular cytogenetics, cytogenetic bioinformatics, genetic consultancy.
TS EN ISO 15189 standard; A standard specific to medical laboratories, created by the regulation of ISO 9001 and ISO 17025 standards for medical laboratories. 15189 accreditation documents; This means that the laboratory meets the technical competence and management system requirements necessary to provide technically valid results and ensures that correct test results will emerge from this laboratory.
ISO 15189 has made significant contributions to our center. Job descriptions have been improved. Quality targets, indicators are determined. Trainings, internal examinations were carried out. Material procurement processes have been improved. Satisfaction surveys were conducted. The QDMS system was switched to the Beam system. Processes were studied with Ensemble. Standardization of laboratory results was achieved by preparing procedures, instructions, supplementary documents and forms. Hardware, maintenance and calibration processes have been improved. Training processes were standardized. Indicators were determined in line with our quality targets and evaluations were made . Patient outcome reports have been improved in line with the standard . Improvements have been made regarding test times. With the QR code system, the clinician was given the opportunity to provide more detailed information in the WES and Clinical Exome reports.